Compare BBBY & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBBY | IVVD |
|---|---|---|
| Founded | 1971 | 2020 |
| Country | United States | United States |
| Employees | 389 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.2M | 437.1M |
| IPO Year | N/A | 2021 |
| Metric | BBBY | IVVD |
|---|---|---|
| Price | $5.75 | $0.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $8.00 | ★ $8.75 |
| AVG Volume (30 Days) | 2.9M | ★ 6.3M |
| Earning Date | 04-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $53,426,000.00 |
| Revenue This Year | $6.35 | $61.57 |
| Revenue Next Year | $7.11 | $41.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 110.47 |
| 52 Week Low | $4.26 | $0.49 |
| 52 Week High | $12.65 | $3.07 |
| Indicator | BBBY | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 41.63 |
| Support Level | $5.41 | $0.73 |
| Resistance Level | $6.48 | $1.01 |
| Average True Range (ATR) | 0.56 | 0.09 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 23.81 | 58.77 |
Bed Bath & Beyond Inc is an e-commerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands, offering products and services that enable its customers to enhance everyday life through quality, style, and value. The company currently owns Bed Bath & Beyond, Overstock, buybuy BABY, and other related brands and websites, as well as a blockchain asset portfolio. Its e-commerce platforms, www.bedbathandbeyond.com and www.overstock.com, are targeted at customers seeking various products such as furniture, bedding, area rugs, tabletop and cookware, decor, storage, jewelry, etc, at affordable prices. In addition to products, the company also offers add-on services across platforms, including warranties, shipping insurance, and installation services.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.